The Impact of Metastatic Directed Radiotherapy (MDRT) on Oligoprogressive Castration Resistant Prostate Cancer (CRPC)

Abroad (travel likely)RecruitingPHASE2

Conditions

Prostate Cancer (Adenocarcinoma) · OligoProgressive Metastatic Disease · Castration Resistant Metastatic Prostate Cancer · Radiotherapy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

UMC Groningen, Groningen, Netherlands
Contact: Study coordinator (Shafak Aluwini) · s.al-uwini@umcg.nl · +31625649975
Radboud Umc, Nijmegen, Netherlands
Contact: Study coordinator (Robert Jan Smeenk) · RobertJan.Smeenk@radboudumc.nl · +31 (024) 361 45 05

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER)

Prostate Cancer · Oligoprogressive · Urothelial Carcinoma

Abroad (travel likely)Recruiting

Sacramento, United States

Online Adaptive Stereotactic Body Radiotherapy for Localized Prostate Cancer

Localized Prostate Carcinoma · Prostate Cancer (Adenocarcinoma) · Prostate Hyperplasia

Abroad (travel likely)Recruiting

Heidelberg, Germany · Munich, Germany

Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy

Prostate Adenocarcinoma · Prostate Cancer · Localized Prostate Cancer

Abroad (travel likely)RecruitingPHASE2

San Francisco, United States · St Louis, United States

A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer

Prostate Cancer · Prostate Adenocarcinoma

Abroad (travel likely)RecruitingPHASE2

Chicago, United States · Dallas, United States